We are live on
!
Find out more
Vaxcyte
PCVX
PCVX
336 hedge funds and large institutions have $9.44B invested in Vaxcyte in 2026 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 129 increasing their positions, 81 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
196% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 24
69% more funds holding in top 10
Funds holding in top 10: 13 → 22 (+9)
59% more repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 81
39% more capital invested
Capital invested by funds: $6.81B → $9.44B (+$2.63B)
14% more funds holding
Funds holding: 295 → 336 (+41)
0.2% more ownership
Funds ownership: 112.72% → 112.93% (+0.2%)
37% less call options, than puts
Call options by funds: $64.8M | Put options by funds: $103M
Holders
336
Holders Change
+41
Holders Change %
+13.9%
% of All Funds
4.14%
Holding in Top 10
22
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+69.23%
% of All Funds
0.27%
New
71
Increased
129
Reduced
81
Closed
24
Calls
$64.8M
Puts
$103M
Net Calls
-$37.9M
Net Calls Change
-$33.5M
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$74.6M |
| 2 |
D.E. Shaw & Co
New York
|
-$41.6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$29.3M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$20.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.1M |
